Study Comparing Digital Avatar-Assisted CBT and Standard Face-to-Face CBT
for Treating Addiction and Intimate Partner Violence in Men Aged 18 to 65
Led by University of Rochester · Updated on 2026-01-26
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a digital, interactive platform called RITchCBT designed to treat Substance Use Disorders SUD and co-occurring Intimate Partner Violence IPV in men entering addiction treatment. This Phase I and II study involves a randomized controlled trial to compare the digital RITchCBT with standard one-on-one face-to-face Cognitive Behavioral Therapy CBT. The study aims to explore the feasibility and effectiveness of this digital therapy approach in reducing both addiction and IPV behaviors among a diverse male population.
The study will enroll 40 male participants diagnosed with substance dependence and recent IPV behaviors, randomly assigned to either digital RITchCBT or standard CBT groups. Each therapy consists of weekly 60-minute sessions over 12 weeks. The digital RITchCBT uses an avatar-assisted interactive approach allowing participants to engage conveniently from home with practice exercises outside sessions. The standard CBT involves manualized, human-administered treatment. If Phase I shows positive results, a larger Phase II trial with 160 participants will follow to further test effectiveness.
Participants will undergo multiple assessments including self-reported cravings, days abstinent from substance use and aggression, breath and urine tests to confirm abstinence, and reports from collateral sources. Primary outcomes are measured weekly during treatment and at follow-ups 3, 6, and 9 months post-treatment. Secondary outcomes include impulsivity and distress tolerance scales, while additional data involve regulatory feedback and submissions. The total participant involvement spans screening, 12 weeks of treatment, and extended follow-ups to monitor progress and safety.
CONDITIONS
Brief Title
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
Research Team
C
Caroline J Easton, PhD
C
Cory Crane, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Digital RITch®CBT (digital CBT)
Human‑administered standard CBT
What it is
A digital cognitive behavioral therapy program (RITch®CBT) delivered via digital platform in outpatient treatment for substance use disorders
Manualized cognitive behavioral therapy delivered by a human therapist in outpatient treatment for substance use disorders
Role in trial
Investigational intervention arm
Active comparator arm
Primary use
Treating alcohol and/or stimulant use disorders in adults
Treating alcohol and/or stimulant use disorders in adults
How it is given or performed
Delivered via a digital platform as RITch®CBT
Delivered in person by a human therapist using manualized CBT
Evidence status
Digital CBT has shown superior longer‑term improvement in abstinence compared with clinician‑delivered CBT in adults with alcohol use disorder in a recent RCT
Standard clinician‑delivered CBT is a well‑established evidence‑based treatment for substance use disorders
Important limitations
Effectiveness evidence is based mainly on alcohol use disorder, with limited data specific to stimulant or combined substance use
Effectiveness varies by delivery setting and may be affected by therapist training and access barriers
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 65Years
MALE
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Male participants aged 18 to 65 years
Meet current DSM-V criteria for substance dependence
Use alcohol and/or stimulants within 30 days prior to screening
Report verbal aggression or conflict in an intimate relationship within 30 days prior to screening
Able to read English at a 6th grade level
You will not qualify if you...
Currently in withdrawal from substances and require detoxification
Cognitive impairment with a mini mental state score less than 25
Have psychomotor epilepsy or seizure-related impulsivity or rage
Major medical complications such as head injury, trauma, or HIV dementia
Currently receiving substance abuse or IPV treatment elsewhere
Lifetime history of psychotic or bipolar disorder
Currently suicidal or homicidal
Severe violence including punching, choking, or use of weapons
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 weeks
Participants receive either a digital avatar assisted interactive CBT treatment or a human administered standard CBT treatment to address substance dependence and related aggression.
Weekly visits for 12 weeks, each lasting 60 minutes
Follow-up
Duration - 9 months
Participants are monitored at 3, 6, and 9 months after treatment to assess substance use cravings, abstinence, and related outcomes.
3 visits (at 3, 6, and 9 months post-treatment)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Testing Combined Neurofeedback and TMS Treatments for Alcohol Use Disorder in Adults Aged 19 to 65
Study of CMND-100 Safety, Dosing, and Effects in Healthy Adults and Adults With Alcohol Use Disorder
Comparing Electronic App-Based and In-Person Brief Interventions to Reduce Risky Alcohol Use in Adults
A Study in Mexico and South Africa
Evaluating a New Blood Test to Help Diagnose and Monitor Depression and Psychosis in Adults
Evaluating Peer Recovery Coaching for Adults Hospitalized with Alcohol Use Disorder to Support Long-Term Recovery and Reduce Heavy Drinking
Study of Brain Stimulation to Enhance Motivational Interviewing for Adults Who Drink Alcohol at Risky Levels
Study Comparing Digital Avatar-Assisted CBT and Standard Face-to-Face CBT
for Treating Addiction and Intimate Partner Violence in Men Aged 18 to 65
Evaluating an Adaptive Web-Based Alcohol Use Disorder Treatment for Military Service Members and Their Partners
Phase 3 Trial of Brenipatide Injection Compared to Placebo for Adults with Alcohol Use Disorder
Phase 3 Study of Brenipatide Compared to Placebo for Adults with Moderate-to-Severe Alcohol Use Disorder
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
A Randomized Controlled Trial Assessing the Efficacy of Cognitive Behavioral Therapy for Substance-Dependent Domestic Violence Offenders: An Integrated Substance Abuse-Domestic Violence Treatment Approach (SADV).